Tomidokoro Yasushi, Lashley Tammaryn, Rostagno Agueda, Neubert Thomas A, Bojsen-Møller Marie, Braendgaard Hans, Plant Gordon, Holton Janice, Frangione Blas, Révész Tamas, Ghiso Jorge
Department of Pathology, New York University School of Medicine, New York, New York 10016, USA.
J Biol Chem. 2005 Nov 4;280(44):36883-94. doi: 10.1074/jbc.M504038200. Epub 2005 Aug 9.
Familial Danish dementia is an early onset autosomal dominant neurodegenerative disorder linked to a genetic defect in the BRI2 gene and clinically characterized by dementia and ataxia. Cerebral amyloid and preamyloid deposits of two unrelated molecules (Danish amyloid (ADan) and beta-amyloid (Abeta)), the absence of compact plaques, and neurofibrillary degeneration indistinguishable from that observed in Alzheimer disease (AD) are the main neuropathological features of the disease. Biochemical analysis of extracted amyloid and preamyloid species indicates that as the solubility of the deposits decreases, the heterogeneity and complexity of the extracted peptides exponentially increase. Nonfibrillar deposits were mainly composed of intact ADan-(1-34) and its N-terminally modified (pyroglutamate) counterpart together with Abeta-(1-42) and Abeta-(4-42) in approximately 1:1 mixture. The post-translational modification, glutamate to pyroglutamate, was not present in soluble circulating ADan. In the amyloid fractions, ADan was heavily oligomerized and highly heterogeneous at the N and C terminus, and, when intact, its N terminus was post-translationally modified (pyroglutamate), whereas Abeta was mainly Abeta-(4-42). In all cases, the presence of Abeta-(X-40) was negligible, a surprising finding in view of the prevalence of Abeta40 in vascular deposits observed in sporadic and familial AD, Down syndrome, and normal aging. Whether the presence of the two amyloid subunits is imperative for the disease phenotype or just reflects a conformational mimicry remains to be elucidated; nonetheless, a specific interaction between ADan oligomers and Abeta molecules was demonstrated in vitro by ligand blot analysis using synthetic peptides. The absence of compact plaques in the presence of extensive neuro fibrillar degeneration strongly suggests that compact plaques, fundamental lesions for the diagnosis of AD, are not essential for the mechanism of dementia.
家族性丹麦痴呆症是一种早发性常染色体显性神经退行性疾病,与BRI2基因的遗传缺陷有关,临床特征为痴呆和共济失调。两种不相关分子(丹麦淀粉样蛋白(ADan)和β淀粉样蛋白(Abeta))的脑淀粉样蛋白和淀粉样前体沉积物、缺乏致密斑块以及与阿尔茨海默病(AD)中观察到的神经原纤维变性无法区分,是该疾病的主要神经病理学特征。对提取的淀粉样蛋白和淀粉样前体物质的生化分析表明,随着沉积物溶解度的降低,提取肽的异质性和复杂性呈指数增加。非纤维状沉积物主要由完整的ADan-(1-34)及其N端修饰(焦谷氨酸)的对应物以及Abeta-(1-42)和Abeta-(4-42)以大约1:1的混合物组成。可溶性循环ADan中不存在翻译后修饰,即谷氨酸到焦谷氨酸。在淀粉样蛋白组分中,ADan在N端和C端高度寡聚且高度异质,完整时其N端进行了翻译后修饰(焦谷氨酸),而Abeta主要是Abeta-(4-42)。在所有情况下,Abeta-(X-40)的存在可以忽略不计,鉴于在散发性和家族性AD、唐氏综合征以及正常衰老中观察到的血管沉积物中Abeta40的普遍性,这是一个令人惊讶的发现。这两种淀粉样蛋白亚基的存在对于疾病表型是否至关重要,还是仅仅反映了构象模拟,仍有待阐明;尽管如此,通过使用合成肽的配体印迹分析在体外证明了ADan寡聚体与Abeta分子之间存在特异性相互作用。在存在广泛神经原纤维变性的情况下缺乏致密斑块,强烈表明致密斑块作为AD诊断的基本病变,对于痴呆机制并非必不可少。